<DOC>
	<DOCNO>NCT00766025</DOCNO>
	<brief_summary>The main purpose study examine Taiwanese subject identify CYP2C19 poor extensive metabolizers take single multiple dose rosuvastatin calcium .</brief_summary>
	<brief_title>Study Taiwanese Subjects Identified CYP2C19 Poor Extensive Metabolizers Receiving Rosuvastatin</brief_title>
	<detailed_description />
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Subject must blood drawn genotyping ( determination EM PM CYP2C19 , determination OATPC1B1 , BCRP 421C &gt; A , CYP2C9 . Males female age 2065 , inclusive Women surgically sterilize , postmenopausal least one year , pregnant and/or lactating . Women childbearing potential must willing abstain sexual activity use effective contraception outline protocol . Subjects deoxyribonucleic acid ( DNA ) cod OATPC 1B1 *5 *15 , BCRP 421C &gt; A and/or non wildtype CYP2C9 History adverse drug reaction hypersensitivity statins drug similar chemical structure rosuvastatin History presence gastrointestinal , hepatic , renal disease condition know interfere absorption , distribution , metabolism excretion ( ADME ) drug Any contraindication determine review detailed medical drug history , complete physical examination , vital sign , blood chemistry , hematology , electrocardiogram ( ECG )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Taiwanese Subjects</keyword>
	<keyword>CYP2C19</keyword>
	<keyword>Poor Metabolizers</keyword>
	<keyword>Extensive Metabolizers</keyword>
	<keyword>Taiwanese Subjects identify CYP2C19 Poor Extensive Metabolizers</keyword>
</DOC>